Functional Interaction among lncRNA HOTAIR and MicroRNAs in Cancer and Other Human Diseases

Monica Cantile1, Maurizio Di Bonito1, Maura Tracey De Bellis2

  • 1Pathology Unit, Istituto Nazionale Tumori-Irccs-Fondazione G.Pascale, 80131 Naples, Italy.

Cancers
|February 5, 2021
PubMed

Insights

Long non-coding RNAs (lncRNAs) regulate cancer by interacting with microRNAs (miRNAs). The lncRNA HOTAIR and its miRNA interactions are crucial in cancer progression, offering potential as biomarkers.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Long non-coding RNAs (lncRNAs) are key regulators in cancer initiation, metastasis, and drug resistance.
  • lncRNAs modulate gene expression by interacting with microRNAs (miRNAs), acting as competing endogenous RNAs.
  • The lncRNA HOX transcript antisense RNA (HOTAIR) is implicated as a biomarker in various human cancers.

Purpose of the Study:

  • To review the relationship between the lncRNA HOTAIR and various miRNAs in human diseases.
  • To discuss the role of HOTAIR-miRNA interactions in cancer development and progression.

Main Methods:

  • Literature review
  • Analysis of functional interactions between lncRNAs and miRNAs
  • Focus on HOTAIR's role in cancer pathogenesis

Main Results:

  • lncRNAs, particularly HOTAIR, significantly influence cancer progression through miRNA sponging.
  • HOTAIR-miRNA interactions are critical for modulating cellular processes in cancer.
  • HOTAIR serves as a potential diagnostic, prognostic, and predictive biomarker.

Conclusions:

  • The interplay between HOTAIR and miRNAs is a critical mechanism in human cancer.
  • Understanding these interactions can lead to novel therapeutic strategies and biomarkers for cancer management.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.2K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K